Company / Capital Expenditures
Phibro Animal Health Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$38.3M
FY2025
5-year range
$29.3M / $41.2M
FY2021-FY2025
Trend
-7.1%
vs FY2024
Sector context
#30 of 194
Health Care
What the data says
Phibro Animal Health's capital expenditures of $38M is higher than 85% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 10 years, ranging from $21M in FY2017 to $41M in FY2024.
Based on SEC 10-K filings.
$38M in FY2025 with a 5-year CAGR of +2.4%. Top quartile in the Health Care sector.
Improved from $29M to $38M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +1.1%
- 5-Year CAGR
- +2.4%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 194This company $38.3M Sector average $117.5M
▼
-67.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.4%, indicating consistent growth.
- In FY2025, capital expenditures decreased 7.1% year-over-year.
- Ranks #30 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $38.3M | -7.1% |
| FY2024 | $41.2M | +40.6% |
| FY2023 | $29.3M | -20.9% |
| FY2022 | $37.0M | +26.3% |
| FY2021 | $29.3M | -13.9% |
| FY2020 | $34.0M | +13.9% |
| FY2019 | $29.9M | -17.8% |
| FY2018 | $36.4M | +74.1% |
| FY2017 | $20.9M | -42.6% |
| FY2016 | $36.4M | +82.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026